Bath & Body Works (BBWI) Projected to Post Quarterly Earnings on Thursday

Bath & Body Works (NYSE:BBWI) is projected to issue its quarterly earnings data before the market opens on Thursday, February 27th. Analysts expect the company to announce earnings of $2.04 per share and revenue of $2.78 billion for the quarter. Bath & Body Works has set its Q4 guidance at $1.94-2.07 EPS and its Q4 2024 guidance at 1.940-2.070 EPS.Parties interested in listening to the company’s conference call can do so using this link.

Bath & Body Works (NYSE:BBWI) last issued its earnings results on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.48 earnings per share. On average, analysts expect Bath & Body Works to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $40.15 on Thursday. The stock has a market capitalization of $8.70 billion, a PE ratio of 9.79, a price-to-earnings-growth ratio of 0.88 and a beta of 1.83. Bath & Body Works has a 52-week low of $26.20 and a 52-week high of $52.99. The company has a 50-day simple moving average of $37.64 and a two-hundred day simple moving average of $33.76.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, March 7th. Shareholders of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 1.99%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Barclays lifted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a report on Tuesday, November 26th. TD Cowen boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Piper Sandler boosted their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $42.00 to $48.00 in a report on Friday, January 10th. Finally, Telsey Advisory Group reissued an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. One research analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and an average price target of $43.56.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.